Parkman Healthcare Partners LLC increased its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 12.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 267,594 shares of the company’s stock after purchasing an additional 29,462 shares during the […]
Avidity Partners Management LP decreased its position in shares of Vaxcyte, Inc. (NASDAQ:PCVX – Free Report) by 24.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 570,137 shares of the company’s stock after selling 186,028 shares during the […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) Director Halley E. Gilbert sold 18,200 shares of Vaxcyte stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $73.00, for a total value of $1,328,600.00. Following the transaction, the director now owns 5,625 shares in the company, valued at approximately […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) SVP Mikhail Eydelman sold 1,667 shares of the company’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $72.06, for a total transaction of $120,124.02. Following the sale, the senior vice president now owns 31,161 shares of the company’s stock, […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) CEO Grant Pickering sold 2,616 shares of the business’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $72.06, for a total transaction of $188,508.96. Following the transaction, the chief executive officer now owns 144,746 shares in the company, valued […]